Favoritar este trabalho
Como citar esse trabalho?
Resumo

Antimicrobial resistance is a serious global concern health system, mainly in Klebsiella pneumoniae infections. K. pneumoniae resistance is a major challenge in medicine since it exhibits resistance to multiple antibiotics and it is associated with nosocomial infections, leading to many deaths each year. Antimicrobial resistance control strategies are needed to avoid the spread of resistant strains, not only in the hospital environment, but with focus on the One Health approach. The development of new therapies focused on eliminating the resistant bacteria or to assist antibiotics activities are needed. In that sense, this study investigated the effect of modulation of the A2B receptor in mice during pneumonia infection by K. pneumoniae. Previous studies have shown that A2B receptor deficiency improves host defense and survival in mice with K. pneumoniae pneumonia (Barletta et al., 2012), suggesting that modulation of this receptor could enhance antibiotic-mediated bacterial killing. For that, Swiss mice received intratracheal instillation of K. pneumoniae and, 6 hours after the infection, they were treated with 1 mg/kg or 5 mg/kg of PSB603, an antagonist of A2B receptor, intraperitoneally. Then, 24h after intratracheal instillation, mice were followed to observe the mortality rate or were euthanized (#L-024-2025). During euthanasia the bronchoalveolar fluid (BAL) was collected to evaluate the levels of cytokines, leukocytes levels, and observe the leukocyte profile in mice lungs. As results, we observed that animals treated with A2B antagonist showed a decrease in survival rate, and clinical score was higher in those groups. The levels of leukocytes in BAL were similar between groups, but animals treated with the higher doses of PSB603 showed an increase in polymorphonuclear cells. CFU in BAL were also quantified and the data showed an increasing tendency in animals that received PSB603 but no difference were observed in proinflammatory cytokine levels.

Compartilhe suas ideias ou dúvidas com os autores!

Sabia que o maior estímulo no desenvolvimento científico e cultural é a curiosidade? Deixe seus questionamentos ou sugestões para o autor!

Faça login para interagir

Tem uma dúvida ou sugestão? Compartilhe seu feedback com os autores!

Instituições
  • 1 Instituto Oswaldo Cruz - Fundação Oswaldo Cruz (FIOCRUZ)
  • 2 IOC/FIOCRUZ
  • 3 Fundação Oswaldo Cruz (FIOCRUZ)
  • 4 Unirio - Universidade Federal do Estado do Rio de Janeiro
  • 5 Fluminense Federal University
Eixo Temático
  • New Therapies
Palavras-chave
Klebsiella pneumoniae
antimicrobial resistance
nosocomial infections
a2b antagonist
pneumonia